HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: vir.0.010082-0v1 90/8/2050    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Dron, M. Articles by Laude, H. Search for Related Content PubMed PubMed Citation Articles by Dron, M. Articles by Laude, H. Agricola Articles by Dron, M. Articles by Laude, H.

Proteasome inhibitors promote the sequestration of PrP^Sc into aggresomes within the cytosol of prion-infected CAD neuronal cells

¹ INRA, U892 Virologie Immunologie Moléculaires, F-78350 Jouy-en-Josas, France
² Centre National de la Recherche Scientifique, FRE2942, Oncologie Virale, F-94801 Villejuif, France

Correspondence
Michel Dron
michel.dron{at}jouy.inra.fr

Dysfunction of the endoplasmic reticulum associated protein degradation/proteasome system is believed to contribute to the initiation or aggravation of neurodegenerative disorders associated with protein misfolding, and there is some evidence to suggest that proteasome dysfunctions might be implicated in prion disease. This study investigated the effect of proteasome inhibitors on the biogenesis of both the cellular (PrP^C) and abnormal (PrP^Sc) forms of prion protein in CAD neuronal cells, a newly introduced prion cell system. In uninfected cells, proteasome impairment altered the intracellular distribution of PrP^C, leading to a strong accumulation in the Golgi apparatus. Moreover, a detergent-insoluble and weakly protease-resistant PrP species of 26 kDa, termed PrP^26K, accumulated in the cells, whether they were prion-infected or not. However, no evidence was found that, in infected cells, this PrP^26K species converts into the highly proteinase K-resistant PrP^Sc. In the infected cultures, proteasome inhibition caused an increased intracellular aggregation of PrP^Sc that was deposited into large aggresomes. These findings strengthen the view that, in neuronal cells expressing wild-type PrP^C from the natural promoter, proteasomal impairment may affect both the process of PrP^C biosynthesis and the subcellular sites of PrP^Sc accumulation, despite the fact that these two effects could essentially be disconnected.